Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB19360ApprovedSmall molecule
Latanoprost acid: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Prostaglandin F2-alpha receptor
- Formula / weight
- C23H34O5 · 390.52 g/mol (avg)
- Also known as
- 13,14-dihydro-17-phenyl trinor pgf2.alpha. · 13,14-dihydro-17-phenyl-18,19,20-trinor-pgf2.alpha. · 5-heptenoic acid, 7-((1r,2r,3r,5s)-3,5-dihydroxy-2-((3r)-3-hydroxy-5-phenylpentyl)cyclopentyl)-, (5z)- · Latanoprost related compound e
- Code names
- PHXA-85
Resolves to
Clinical / RWD
Structure
InChIKey
HNPFPERDNWXAGS-NFVOFSAMSA-NSMILESO[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O)CCC1=CC=CC=C1Targets
Transporters
What you can answer from here — as of September 23, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Latanoprost acid, and which of those have an active Phase 3 trial?